Reciprocal cross-talk between P2Y1 and P2Y12 receptors at the level of calcium signaling in human platelets
- 15 September 2004
- journal article
- Published by American Society of Hematology in Blood
- Vol. 104 (6) , 1745-1752
- https://doi.org/10.1182/blood-2004-02-0534
Abstract
Adenosine diphosphate (ADP), an important platelet agonist, acts through 2 G-protein-coupled receptors (GPCRs), P2Y1 and P2Y12, which signal through Gq and Gi, respectively. There is increasing evidence for cross-talk between signaling pathways downstream of GPCRs and here we demonstrate cross-talk between these 2 ADP receptors in human platelets. We show that P2Y12 contributes to platelet signaling by potentiating the P2Y1-induced calcium response. This potentiation is mediated by 2 mechanisms: inhibition of adenylate cyclase and activation of phosphatidylinositol 3 (PI 3)-kinase. Furthermore, the Src family kinase inhibitor PP1 selectively potentiates the contribution to the calcium response by P2Y12, although inhibition of adenylate cyclase by P2Y12 is unaffected. Using PP1 in combination with the inhibitor of PI 3-kinase LY294002, we show that Src negatively regulates the PI 3-kinase-mediated component of the P2Y12 calcium response. Finally, we were able to show that Src kinase is activated through P2Y1 but not P2Y12. Taken together, we present evidence for a complex signaling interplay between P2Y1 and P2Y12, where P2Y12 is able to positively regulate P2Y1 action and P2Y1 negatively regulates this action of P2Y12. It is likely that this interplay between receptors plays an important role in maintaining the delicate balance between platelet activation and inhibition during normal hemostasis. (Blood. 2004; 104:1745-1752)Keywords
This publication has 54 references indexed in Scilit:
- The roles of αIIbβ3-mediated outside-in signal transduction, thromboxane A2, and adenosine diphosphate in collagen-induced platelet aggregationBlood, 2003
- Molecular bases of defective signal transduction in the platelet P2Y 12 receptor of a patient with congenital bleedingProceedings of the National Academy of Sciences, 2003
- Convulxin induces platelet shape change through myosin light chain kinase and Rho kinaseEuropean Journal of Biochemistry, 2002
- Platelet collagen receptor integrin α2β1activation involves differential participation of ADP‐receptor subtypes P2Y1 and P2Y12 but not intracellular calcium changeEuropean Journal of Biochemistry, 2001
- Identification of the platelet ADP receptor targeted by antithrombotic drugsNature, 2001
- ADP-induced platelet shape change: an investigation of the signalling pathways involved and their dependence on the method of platelet preparationPlatelets, 2000
- Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y1 receptor–null miceJournal of Clinical Investigation, 1999
- Antagonists of the Platelet P2T Receptor: A Novel Approach to Antithrombotic TherapyJournal of Medicinal Chemistry, 1999
- Deficiency of (33P)2MeS-ADP Binding Sites on Platelets with Secretion Defect, Normal Granule Stores and Normal Thromboxane A2 ProductionThrombosis and Haemostasis, 1997
- Purinoceptors on blood platelets: further pharmacological and clinical evidence to suggest the presence of two ADP receptorsBritish Journal of Haematology, 1995